Cargando…
Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis
BACKGROUND: Both chemoradiotherapy and chemotherapy are used in postoperative adjuvant therapy for resected gastric cancer. However, it is controversial whether chemoradiotherapy or chemotherapy is the optimal strategy for patients with gastric cancer after D2 lymphadenectomy. The present meta-analy...
Autores principales: | Huang, Yuan-Yuan, Yang, Qiong, Zhou, Si-Wei, Wei, Ying, Chen, Yan-Xian, Xie, De-Rong, Zhang, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715514/ https://www.ncbi.nlm.nih.gov/pubmed/23874819 http://dx.doi.org/10.1371/journal.pone.0068939 |
Ejemplares similares
-
Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis
por: Huang, Yuan-Yuan, et al.
Publicado: (2013) -
Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
por: Yang, Qiong, et al.
Publicado: (2013) -
A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomy
por: ZHAI, YU-JIE, et al.
Publicado: (2014) -
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis
por: Zhou, Meng-long, et al.
Publicado: (2016) -
Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials
por: Song, Jin Ho, et al.
Publicado: (2017)